Fjarde Ap Fonden Abbott Laboratories Transaction History

Fjarde Ap Fonden

$9.04 Billion
Q1 2024

A detailed history of Fjarde Ap Fonden transactions in Abbott Laboratories stock. As of the latest transaction made, Fjarde Ap Fonden holds 278,788 shares of ABT stock, worth $29 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

278,788

Previous 269,788 3.34%

Holding current value

$29 Million

Previous $29.7 Million 6.7%

% of portfolio

0.35%

Previous 0.37%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$109.52 - $120.96 $985,680 - $1.09 Million	9,000 Added 3.34%	278,788 $31.7 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $5.92 Million - $7.24 Million	-65,600 Reduced 19.56%	269,788 $29.7 Million
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $1.62 Million - $1.95 Million	-17,000 Reduced 4.82%	335,388 $32.5 Million
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $15.6 Million - $17.4 Million	155,000 Added 78.53%	352,388 $38.4 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $8.34 Million - $9.82 Million	-86,150 Reduced 30.38%	197,388 $20 Million

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $6.64 Million - $7.79 Million	-69,871 Reduced 19.77%	283,538 $31.1 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $8.71 Million - $10.5 Million	85,300 Added 31.82%	353,409 $38.4 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $18.6 Million - $22.7 Million	-163,300 Reduced 37.85%	268,109 $31.7 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $3.48 Million - $4.27 Million	-30,150 Reduced 6.53%	431,409 $60.7 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $2.19 Million - $2.43 Million	-18,800 Reduced 3.91%	461,559 $54.5 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $2.49 Million - $2.93 Million	-23,500 Reduced 4.66%	480,359 $55.7 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $446,244 - $525,743	4,100 Added 0.82%	503,859 $60.4 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $18.9 Million - $20.6 Million	180,000 Added 56.29%	499,759 $54.7 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $1.69 Million - $2.05 Million	18,400 Added 6.11%	319,759 $34.8 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $1.38 Million - $1.76 Million	18,000 Added 6.35%	301,359 $27.6 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $1.68 Million - $2.45 Million	-26,700 Reduced 8.61%	283,359 $22.4 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $15.8 Million - $17.6 Million	-201,385 Reduced 39.38%	310,059 $26.9 Million
Q3 2019 Oct 31, 2019	BUY	$81.84 - $88.74 $161,306 - $174,906	1,971 Added 0.39%	511,444 $42.8 Million
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $539,312 - $629,000	-7,400 Reduced 1.43%	509,473 $42.8 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $7.48 Million - $9.04 Million	112,888 Added 27.94%	516,873 $41.3 Million
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $4.05 Million - $4.59 Million	-61,800 Reduced 13.27%	403,985 $29.2 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $1.15 Million - $1.39 Million	-18,922 Reduced 3.9%	465,785 $34.2 Million
Q2 2018 Jul 12, 2018	BUY	$57.57 - $63.54 $355,725 - $392,613	6,179 Added 1.29%	484,707 $29.6 Million
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $120,924 - $136,719	2,149 Added 0.45%	478,528 $28.7 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $3.75 Million - $4.02 Million	69,876 Added 17.19%	476,379 $27.2 Million
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $248,133 - $276,943	5,163 Added 1.29%	406,503 $21.7 Million
Q2 2017 Aug 08, 2017	BUY	N/A	401,340	401,340 $19.5 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account